Good afternoon, ladies and gentlemen, and welcome to Kemper's fourth quarter 2021 earnings conference call. My name is Tania, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded for replay purposes. I would now like to introduce your host for today's call, Karen Guerra, Kemper's Vice President of Investor Relations. Ms. Guerra, you may begin. Thank you, operator. Good afternoon, everyone, and welcome to Kemper's discussion of our fourth quarter and full year 2021 results. This afternoon, you'll hear from Joseph P. Lacher, Jr., Kemper's President, Chief Executive Officer and Chairman, James McKinney, Kemper's Executive Vice President and Chief Financial Officer, Duane Sanders, Kemper's Executive Vice President and the Property and Casualty Division President. We'll make a few opening remarks to provide context around our fourth quarter results, and then open the call for a Q&A session. During the interactive portion of our call, our presenters will be joined by John Boschelli, Kemper's Executive Vice President and Chief Investment Officer, Erich Sternberg, Kemper's Executive Vice President and Life and Health Division President. After the markets closed today, we issued our earnings release and published our earnings presentation and financial supplement. We intend to file our Form 10-K with the SEC on or about February 10th. Our discussion today may contain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the company's outlook and its future results of operations and financial conditions. Our actual future results and financial conditions may differ materially from these statements. These statements may also be impacted by the COVID-19 pandemic. For information on additional risks that may impact these forward-looking statements, please refer to our 2020 Form 10-K, as well as our fourth quarter earnings release. This afternoon's discussion also includes non-GAAP financial measures we believe are meaningful to investors. In our financial supplement, earnings presentation and earnings release, we have defined and reconciled all the non-GAAP financial measures to GAAP where required in accordance with SEC rules. You can find these documents on the investors section of our website, kemper.com. All comparative references will be to the corresponding 2020 period unless otherwise stated. I will now turn the call over to Joseph. Thank you, Karen. Good afternoon, everyone, and thank you for joining us. Earlier today, we reported our fourth quarter and full year results. It goes without saying we were disappointed with our profitability. The pandemic-driven environmental challenges we've discussed in the last couple of quarters not only remain, but have intensified. These challenges have impacted each of our businesses. In P&C last quarter, we discussed the relationship between earned rate and loss severity. We talked about the fact that loss inflation is immediately incurred and negatively impacts results. Rate increases are subject to regulatory approvals, roll on to policies of renewal, and are earned over the life of the policy. The benefit of those increases is therefore delayed. The suspension of rate increases during the pandemic and the inflation surge that came with reopening the economy has created an historic mismatch between policy costs and pricing. In the fourth quarter, we continued to see increases in inflation-driven loss severity. Labor rates, auto body repairs, and rental car rates all continue to rise due to inflationary trends related to supply chain issues and labor shortage. As an example, in 2021, used car prices were up 51% from 2019 and 37% over 2020. In the last quarter alone, they were up 9%. These increases in costs have a direct and immediate impact on our margins and did not moderate. To respond to this environment, during the quarter, we made significant progress on both rate and non-rate profit improvement. Overall, we exceeded our targets for the number of rate filings submitted, the percentage of our book impacted, and the level of rate increases approved. These actions will favorably impact future results. We see this aggregate inflation rate imbalance continuing in the short term. Due to the actions we have taken and will continue to take, we believe the situation will stabilize and ultimately restore margins to appropriate levels. Progress will initially be gradual, then more rapid as earned rate benefits are fully realized. The Life and Health segment continues to be negatively impacted by the pandemic. In the quarter, the business continued to incur excess mortality. Throughout the initial wave, then the Delta variant, and now Omicron, our excess mortality rates have remained largely in line with national trends. In summary, we closed the year making significant progress that will become increasingly visible in our results. We are actively taking rate and non-rate actions to restore our margins and are working to accelerate this process every way possible. Duane will discuss more shortly. Unfortunately, the most significant improvement levers will take time. It's a little like planting tomatoes after the winter. You can't start until after it warms up, and it's gonna take 80 days before you can eat the fruit. There's no way to get the fruit faster. We couldn't take rate until frequency rebounded from the lockdowns. Once filed, rate takes time to bear fruit. There isn't a way to meaningfully accelerate it. Though it will take time, we are confident our actions will be successful and position us for growth. I'll now turn the call over to James to discuss our operating results in more detail. Thank you, Joseph. Let's turn to page four. For the quarter, we generated a net loss of $106 million or $1.66 per share as reported, and $101 million or $1.59 per share as adjusted for acquisitions. We also produced an adjusted consolidated net operating loss of $131 million or $2.05 per share as reported, and $126 million or $1.98 per share as adjusted. Earned premium increased 12% on a reported basis and 5% after adjusting for the AAC acquisition. The net loss for the quarter was primarily driven by environmental headwinds that impacted loss costs throughout our P&C businesses. Our focus has been and will remain on restoring temperate to target profitability. During the third and fourth quarter, combined, the P&C teams filed for approximately 11 points of rate on 56% of our personal auto books. Further, the team executed a number of underwriting and non-rate actions to improve margins. Duane will provide greater detail on this topic later. Turning to page five. Return on tangible equity, excluding unrealized gains, was -4.9%. This is below our targeted long-run return. Excluding unrealized gains, tangible book value per share declined $7.21 compared to last December. Of this change, $3.11 is related to the acquisition of American Access and the corresponding goodwill the transaction created. The corrective actions we have taken and are taking in response to higher loss cost trends will over time enable us to achieve our historical value creation levels. On page six, we highlight our view of operating income that continue to be negatively impacted by environmental challenges. As mentioned earlier, this quarter we witnessed higher severity, leading to our Specialty P&C segment reporting an as-adjusted underlying combined ratio of 119%. In addition, in our Life and Health segment, we continue to experience elevated life benefit costs due to excess COVID-related mortality and increased persistency. On page seven, we review some of the key capital metrics we use to track our performance, including growth in tangible book value per share and tangible return on equity. For the last few quarters, we have been below target. We believe these challenges to be short-term in nature and do not expect them to impact our long-run targets. Recent performance is a direct result of the environmental challenges impacting the industry. While this is disappointing, we've instituted and will continue to institute corrective measures to restore the business to target profitability. On page eight, we highlight the strength of our balance sheet. Our substantial capital and liquidity positions enable us to navigate and optimize within the current environment. We continue to produce strong cash flow, generating over $350 million for the year. This has enabled us to continue to make investments in our business and optimize our geographic footprint for the long-term profitable growth. Our insurance entities are well capitalized. Liquidity remains strong and our debt-to-capital ratio of 21.9% remains within our target range. Moving to page nine. We provide an overview of the highlights to our multi-year excess of loss reinsurance and our annual aggregate catastrophe programs. Each year, we review our programs to align with our risk appetite and to minimize our cost to capital. For 2022, we purchased an additional $75 million in limits in our excess of loss program due to our Specialty Auto growth. Our program will cover losses at 95% of $300 million in excess of $50 million. In addition, we renewed our catastrophe aggregate program with a $5 million increase in the retention level. This program is intended to reduce earnings volatility from high frequency, low severity events. Increased limits and the corresponding costs were offset by savings on the Cat Ag program. Thus, there was minimal impact to our year-over-year costs. Turning to page 10. Net investment income for the quarter was $108 million. Our portfolio construction is designed to match liabilities and provide stable income through various cycles. This quarter, we generated a pre-tax equivalent yield of 4.6%. In closing, the company's quarterly financial performance continues to be pressured by various environmental factors. We are confident that the corrective actions we have taken and are taking will, over time, return us to our financial targets. With that, I'll now turn the call over to Duane, who will provide details on our P&C segments. Thank you, James, and good afternoon, everyone. Let's turn to page 11. Last quarter, we introduced this slide to help illustrate the working dynamics we are navigating. At the onset of the pandemic, miles driven and accident frequency were historically low. During this time, Kemper had effectively no rate increases, and additionally, along with most major carriers, delivered premium rebates to customers. As we emerged from lockdowns, we saw loss trends shoot up against pre-pandemic unchanged rates. These dynamics will continue to put pressure on margins in 2022 as the written rate translates to earned rate later in the year. This illustration is intended to bring clarity and context to the profit restoration journey. As the diagram highlights, the inflationary and rate curves create several potential paths and timelines to get there. Moving to page 12. We'll begin with the Specialty P&C. Against the challenging backdrop of inflationary trends related to labor shortages and supply chain issues, along with frequency reaching pre-pandemic levels, the segment experienced an underlying combined ratio year-over-year increase of 28 points, a sequential quarter increase of 11 points. Despite this quarter's loss and temporary rate imbalance, our view of long-term profitability of the business remains highly favorable. The chart on the upper right shows the progress made in obtaining rates throughout the year, including an approximate timeline on how actions will earn through our business. For example, during the fourth quarter, we filed for approximately 8% rate on roughly 57% of our book, with much of the 2021 rate already effective. We're in the process of filing for an additional 7% on 60% of our specialty book in the first quarter. Understandably, it takes time for filed and effective rate to be written and earned into our results. We expect the majority of the filed rates in 2021 to be earned in 2022, with the most significant earned impact in the second half of the year. Now let's turn to page 13. The Preferred P&C segment continues to face similar challenges. Looking at the chart on the upper right, we filed for approximately 12% rate on roughly 23% of our Preferred auto book during the fourth quarter. We're in the process of filing for an additional 10% on 17% of our book in the first quarter. In summary, the organization is focused on the most important levers to restoring profitability. I'll now turn the call back to Joseph. Thank you, Duane. As we turn to our Life & Health segment on page 14, we highlight that life earned premium increased 5% due to persistency improvement. The face value of in-force policies continues to increase, driven by higher persistency and new business sales. We also observed and are encouraged by strong consumer demand for our products. Lastly, our mortality results remain in line with countrywide trends. As the mortality impacts of COVID subside, life mortality and benefit costs should revert to more normalized levels. In closing, although we're disappointed in this quarter's financial results, I couldn't be prouder of our team and how our organization has responded to the circumstances and challenges of the last couple of years. We remain focused on managing through these circumstances, returning to target profitability, and expanding on our long-term competitive advantages. I'll now turn the call over to the operator for questions. Thank you. If you would like to ask a question, please press star followed by one on your telephone keypad. If for any reason you would like to remove that question, please press star followed by two. Again, to ask a question, press star one. As a reminder, if you are using a speakerphone, please remember to pick up your handset before asking your question. We will pause here briefly as questions are registered. The first question is from the line of Gregory Peters with Raymond James. Your line is open. Good afternoon, everyone. I'd like to just focus on the information you provided in slides 11, 12, and 13. On 12 and 13, particularly of interest was where you give us a chart in the upper right-hand corner defining how much rate has been filed for and how much should be impacting the first quarter results in 2022. You know, you look at both for Specialty and Preferred, you see that the amount of rate impact is gonna be less than what the deterioration has been. I guess I'm looking for a reconciliation of that as we think about first quarter, second quarter, third quarter. The other piece of this is there's more than just rate that you can do to improve your results, and you know this. You can cancel agents. You cannot, you know, you can be more strict on new business. I'm curious what's going on on that side of the underwriting house, if possible. Sure, Gregory. This is Joseph. I'll take a shot at it, and then. First, let me walk you through the top right corner of 12 and 13 a little bit to make sure. It is intended to let you see sort of how things waterfall their way through. Let's use 12 as the example. In the third quarter of 2021, we filed for rate on 34% of our premium, and its weighted average was 3%. That also happened to be effective in that quarter. You're getting a written impact in the quarter of 1.8% of rate and 0.1% earned. Those are not just from the third quarter. Those are from all prior that occurred during the pandemic. What you see when you drop to the fourth quarter is we filed for rates that had 57% of our premium impacted, and for 8% rate. Only 37% of that was effective. That means there was another 20% that's filed, but it's still pending department approval. The overall impact of 3.5 written and 0.5. That maps to some combination of what occurred in the second and third quarter as well. We're trying to help you see how each of these works their way through. It's not intended to be a perfect. You can't quite see it without providing a massive set of tables to work those things across. Ultimately, we expect you're gonna wanna understand the earned impact, and how that works through loss ratios, and that will come over time as you work it from now. We are clearly doing a variety of non-rate actions. We are canceling agents. We have adjusted new business, underwriting tiering. We are working with commissions. We are doing a whole lot from a non-rate perspective. We're changing billing plans and adjusting what risks we write. All of those things are occurring fairly significantly across our book of business, and those do have a tendency, depending on the activity, to have a quicker earned impact. And so they are coming. They're a little bit less crystal clear to quantify in this kind of chart. Is that, Gregory, is that helping or? Yeah, that was a great explanation of the charts. You know, I guess, Joseph, everyone's you know listening in on this call just wondering when that inflection point. You know, you look at the chart on page 11 and, you know, rates meeting or exceeding loss trends is the holy grail that everyone wants you to get to. You know, are we gonna see more deterioration before it starts to stabilize and improve? Or, you know, is this as bad as it's gonna get? The timing, when will we get to that holy grail? Yep. Those are exactly the right questions. I'm literally gonna go back to a couple of comments I made. The complexity of five eleven is what is loss trend gonna be going forward and for how long, and how fast do regulators allow rate to be effective. We can control the non-rate activities and move those relatively briskly. I don't think if we back up a quarter or two quarters, we were in early view that inflation was gonna start rising. I think most folks thought we were pessimistic and weren't predicting what was coming. I think most of the industry projection of what's coming. I'm not 100% sure where that's gonna be over the next couple of quarters. I do know that we are seeing the regulatory environment recognizing the uniqueness of this space. Not everyone, but I, you know, we've had great success in, say, Florida and Texas, making multiple rate filings for significant amounts of rate that are moving us along that path. That in fact is the, you know, the $24,000 question that we're dealing with. Our sense is the fourth quarter tends to be a seasonally worse quarter, and the first quarter tends to be a seasonally better quarter. That might be, you know, several points, two, three, four points even, that are a plus. You wouldn't have seen a lot of the non-rate impact in the third quarter. You'll see a little in the fourth, and you'll see more coming in the first and second. Got it. I guess, you know, the other big state is California. I know if you go over a certain rate filing, you'll all of a sudden get the consumer advocate involved, et cetera. Can you give us an update on how your negotiations are progressing with the state of California? Sure. At this point, we have four programs in California. All four programs have had a rate filing introduced to the department close to the 6.9%, just under 7% threshold that you just described. Several of them have been accepted and moved into analyst. Several of them are relatively recent in terms of when we got the. Not during the fourth. I believe our rate filing was one of the first. I think it was the first to move from sort of that to be viewed by and worked on by an analyst. We felt good about that. We're working through the process with the insurance department. I have a reasonable degree of confidence that the insurance commissioner and the department are thoughtful about all of the issues that are going on. They recognize, like other insurance departments around the country, that loss inflation is running high. It's a historic issue that we're dealing with from an industry perspective. It really is important to them to keep vibrant, viable, open markets in terms of what they're doing. I think they're gonna recognize that moving on is critical to the health of the industry and health of the market overall. I'm optimistic that they'll be responsive. Got it. I guess the last question, I know there's others that wanna ask questions, so this will be my last one. Prior year development, can you comment on both the prior development in the Specialty Auto and the other parts of your business, please? Yeah, sure. In Specialty, a relatively marginal favorable, you know, developments come through on some of the coverages like BI, but I wouldn't highlight, you know, a larger broad trend other than I would indicate, you know, we continue to try to make sure we're making thoughtful reserve selections. You know, that you just saw a little bit of favorability relative to that. In terms of the PI book, what I would suggest and what we've seen a little bit coming in from that front is some increased costs associated with litigation in New York with some of our policyholders and some of the other traditional trends we're seeing. Nothing here really from a really new trend perspective, but you know, an item that's kind of working through relative to just the way that accidents and some of the behavior changes that you know, as a result of the pandemic. With that, we saw a couple of those data points and then reacted to them this quarter just to make sure that we're in the right spot. Got it. Thanks for your answers. Thank you, Mr. Peters. The next question is from the line of Paul Newsome with Piper Sandler. Your line is open. Good afternoon. Thanks for the call. Always tough to have tough results, but I know you guys are working as hard as you can to right the ship. First question, just a simple one. That's roughly the 40% that's not getting rate, or actually that hasn't got the impact rate in specialty. Is that the California book, or is that just too simple a way to look at it? Yeah, it's a good question, Paul. Maybe the chart's causing us a challenge. That's not a cumulative set. It's not that there was 34% in the third quarter then another twenty-three got in. That is 34% of the premium got it and an additional 57% and an additional 60% will get it in the first. So in some cases, what you've got is some are getting their second or third helping. So included in the 57% and the 60% is all of our California books. Some of them were in the 57%, some of them were in the 60%. Every book we have in California in Specialty Auto has received an increase. In some cases, as an example, I believe, you know, Florida was in the 34%, and Florida was also in the 57%. They're incremental, not cumulative. Again, you can pull the rate filings in individual states, and you can see them. We were trying to get in a way that let us see the total overall in this process. Okay, great. I mean, the information is definitely helpful. One of the biggest points where there is kind of a delay between the effective and then eventually the earned, to your point, yes, a bigger chunk of that is California at this stage. Again, you can track timing of approval the same as us with online filings. It will be delayed, and then there'll be an implementation date that's probably 45 days out from whenever that, you know, approval comes in. That is what it is. You know, we'll continue to update the tables and hopefully what you've seen is a good consistency here with these. We're trying to provide as much insight here as possible to try to enable that. No, the data is definitely very helpful. You've already touched on this, but you know, normally the fourth quarter for you guys is a little bit of a worse quarter from a seasonal impact in a couple points. Anything beyond that, you know, given the unusual nature of today's environment that would sort of change that seasonality if we could sort of pull out all the pandemic stuff? Yeah, Paul, not that we know. I think the big item, and I think, you know, Joseph highlighted this in some of his comments in that when you see inflationary trends, and we're giving it purely in the example side here, for example, used car prices, and you see 9%, you know, quarter sequential quarter-over-quarter growth, those are big numbers. To the extent that they're gonna move like that and continue to move like that, and, you know, for the year, 37. So what that tells you is that's not really slowed down yet. To the extent the economy slows down a little bit or people's behavior tends, like, they're not gonna go up for forever. It is an element that does depreciate. There's probably an elongation to some degree of the utility in that depreciation curve to some extent that will take a while kinda given just what you know, the supply-demand imbalance is. Until we see some moderation or stability in those things, I think it's gonna be a little bit, you know, more volatile than what we would normally like. I think that pressure potentially, you know, exists up and down, right, when it comes to these things, because once you do have the right supply, you do have some of these things normally. You know, again, this is a depreciating asset that has a limited value and a limited life to it. So it will go to zero at some point in time. You know, we're just not seeing that at this stage. Great. Last question. I'd like to ask a little bit more on capital. It looks like overall capital is fine, but I noticed the RBC capital ratio in the P&C business. You're down a bit in 2021. But at the same time, you are growing PIF, at least in the Specialty business. Does that suggest that you might be pushing capital down into the P&C business over the next year? It's very possible that we would. I mean, what we highlighted is that the Holdco is here to serve as strength for our insurance entities and our businesses. To the extent that, you know, we're not where we would want to be from, you know, in terms of our risk appetite or other elements in terms of prudent, we would make injections appropriately. We have plenty of capital and liquidity available at the Holdco to do that without creating any type of pressure or other. You know, we're gonna navigate through this environment very thoughtfully, and we're gonna make sure that our entities remain strong and capitalized, and really, you know, when policyholders and others would look at us, they're gonna know that Kemper is more than able to stand behind our promises, and we're also gonna know that we're able to, you know, we're not gonna make any rash or decisions or other that are forced on us. We've got a strong, stable business that we can optimize through this environment. Thanks. Thanks for the help, guys. Thanks, Paul. Thank you, Mr. Newsome. The next question is from the line of Gary Ransom with Dowling & Partners. Your line is open. Yes, good evening. You may have already sort of answered this on the fourth quarter loss ratio and seasonality, but was there any true-ups for the current accident year that might have run through the number in the fourth quarter? Yeah. There's roughly about two points in the preferred book that I think you're most focused on that's running through. It's relatively largely focused on the third quarter. What you're seeing is some increased inflation severity trends, not necessarily in our paid, but in terms of how we expect those to play out as we continue to move forward in the future and what we think that inflationary environment is gonna be on our collision coverages. That's there. Again, inflation, especially in used cars, continues to run hotter, even hotter than our, you know, probably higher projections than most. That's driving a component of that. We also saw, you know, a little bit on the BI front, just again, not necessarily in the page up into that point in time, but we're looking at kind of increased inflationary trends, looking at, you know, differences as it relates to, you know, behavior changes, whether it be attorney, rep rates or other elements. We've reacted a little bit to that, from an LAE perspective to make sure that we've got that accounted for on a go-forward basis. We'll see how that kind of comes together. There's about two points, in summary, that is inside there. Was there anything from the Florida PIP issue or did those estimates hold from last quarter? No, those estimates have held. No, no further update. Have held. Okay, great. Thank you. I also wanted to ask about frequency. I think last quarter you more or less talked about frequency coming back to 2019 levels more or less within a point. Is that still generally the case? That is still the case. No change from that front at this- Okay. I mean. I guess that's it for me. Thank you very much. Severity versus the frequency. I think what you're really trying to ask is this a frequency item or is this a severity item? Right now based on our reviews and when we pull back the covers in every which way direction, what we come out with, and it'll be interesting once we get other Schedule Ps in that because I think they'll provide some additional comparison points. We're seeing this as a severity event. There's nothing from an underwriting perspective or otherwise that we're seeing these large changes. We just see the costs associated with items increasing. We're trying to react to that the best that we can. The industry structurally isn't really set up for 50% kind of two-year type changes or other. Now we'll work through it. It's not the, you know, it just takes time to get through these. It's not whether, you know, it's not an if, it's just a when, and we're working that as fast as we can at this stage. It's principally in metal coverages. You know, so it's a severity issue, frequency, and it's predominantly inside of the metal coverages. Thank you very much. Thanks, Gary. Thank you, Mr. Ransom. The next question is from the line of Brian Meredith with UBS. Your line is open. Yeah, thanks. A couple of questions here for you. First, just a clarification. I just want to understand that I'm getting this chart on page 12. If I look at the overall impact on a written basis, I think what you're saying is that these are individually by quarter what the written impact is. The cumulative impact by the end of the first quarter should be something north of 11%. Am I getting that right? No. What you should do is say that 5.8%, that's the cumulative impact on written- Oh. Of all of those. What it is Gotcha. For it to be written, that policy had to either been new or renewed. As an example- Okay. All right. If that third quarter 2021 number, if it had been approved in August, it might not be and effective. It will not hit some of those policies on renewal. It'll hit some in September, some in October, some it won't hit till March or April. That 37% that became effective in the fourth quarter, some of that was, let's say in November or December. The first policy that actually gets the impact of that would be a January. If it was a 12-month policy, you'd get one quarter of it in the year. If it was six-month policies, you'd get half in the first quarter. That is intended, you know, on the right side of the dotted line to show you the cumulative impact. Normally this would be a really hard chart to read. There wasn't a lot of rate that was running. So it is intended to give a cumulative. Again, I don't think it's gonna be different than most folks have out there. I think we're just trying to put it in a way that you can sort of illustratively see it working its way in. It will accelerate. Yes. Rapidly as you get into the second and third quarter, because of everything you see. If you just do the math on what you see running through the fourth and the first, that surge comes through. Okay, great. That's helpful. Then just quickly, just clarification. Your policies are six-month policies, right? So, why some people are just a little surprised that the earned impact was as low as it was. No, we've got a mixture of policies. Effectively, we have more six-month policies, I think, than most preferred standard carriers. You know, more than 50% of the book is gonna be 12-month policies that are coming through there. Oh, even in your Specialty segment? Yeah, even in our specialty segment. Because, again, we're careful to say inside a specialty, it's specialty, not just non-standard. The non-standard part of it is predominantly six-month policies. But there are pieces of this where we very specifically might look at it and say it's another specialty, the Hispanic customer segment. There are pieces of this that are non-standard, and there's pieces of it that are closer to standard. Gotcha. Okay, helpful. Any difference in underwriting profile that's deliberate on our part. Okay, that makes sense. And then I'm just curious, going back to the non-rate actions, maybe give us some perspective. How much of an impact would you expect that to have as far as getting back to your profitability? Is it a quarter of it, a half of it? Because if I just take a look at where you are right now with your loss ratios, I mean, it looks like you need, assuming loss trend is zero, 20%-25% cumulative rate to get back to your kind of normalized margins. Now, that's about assuming non-rate action. So how much will that contribute? I'm trying to figure out how to get to exactly the answer you want, Brian, and I understand it, and I'm gonna give you an answer, and then we'll talk about it a little bit, and you'll understand it. It ultimately probably comes in to somewhere around a third to a half. Now I'm gonna get to be a little bit of an insurance, you know, wonk and mechanic. You know, we could adjust commission a point or two. If we did it, that would affect, you know, and have sort of an immediate earned impact. That gets you to something. We have in a lot of our programs, underwriting tiers that there's an ability inside of the same rate level to move you to a higher. How those are slotted. That doesn't change the renewal book, but that does change the new business coming in. That sort of has an immediate impact on what's running through new. We could eliminate an agency. Well, that might stop new business on that for that agency, but it doesn't immediately cause their new business, I mean, their renewal book to go away. There are pieces of this that go in immediately across the whole book, new only or might have. We're working all of those at this point. I mean, there's some stuff we can do just on general expenses underneath. We're working all of those. The first third of the non-rate actions get felt fastest, and the back, you know, half or two thirds go a little slower. I'm trying to get you the precision you want because I know what you want to do is exactly what I would want to do is put it into that helps you project the loss ratio and combined ratio improvement. I'm not sure how to capture it in precisely the way that I think you're looking for it. Okay. Well, that's helpful. That helps a lot. Then maybe we can focus a little bit just on top line and kind of what are your expectations, you know, over the next 12 to 18 months as you fix this problem? What's gonna happen with respect to, you know, PIF counts in your specialty business? Maybe a little bit on how you manage or handle your distribution in periods like we are right now. Yeah. We're pushing pretty hard on underwriting restrictions. Some of this is gonna be a function of what's competitively done in the market. I would expect the business will be flat and maybe down some over the near term. We would be happy or very comfortable if it was down a little more than that in the near term. The more underwriting disruption one company provides, the more everybody's doing that, there's less of a place for it to land. You can more quickly impact new business, but sometimes you actually see a little uptick in retention, because it's harder for those customers to move, and they deal with the underwriting or pricing things that are happening to them. It's not completely clear the pace with which the market's also moving. I would expect that we'll be closer to flat or down some inside of Specialty and would be comfortable with down a bit more near term. Okay. I guess my last quest- Go ahead. Yeah. I would think just to be careful to split this between PIF and kind of written and earned. You know- Mm-hmm. I agree. For the PIF, I would suggest that the written or earned will likely exceed and continue to grow as a result of both the pricing and the underwriting actions that we're taking. Probably some slight deterioration maybe on the PIF side, but I would hold, again, a lot of market components associated with that and how things will move. We'll see. Definitely, I think you're gonna see, you know, continued strong, probably earned and written growth as both the rate and underwriting actions continue to earn in. Yeah, that's a perfect clarification. Gotcha. All my comments were PIF related. Yep. Definitely with the rate activity, I would expect the written and earned to go up. Gotcha. Last question for you. Let's think out 12-18 months from now and what potential opportunities are. I mean, I would think that if you all are seeing these types of issues and some of your larger competitors are, the small to mid-sized players that you know compete a lot with, and that's where you're really targeting, must be having a really difficult time right now. Do you see opportunities kind of both inorganically and organically kind of really grab share, call it once profitability gets to where you need it to be? Two pieces of it. One, we are 100% focused right now on focusing on restoring our underlying profitability. I would be shocked if we don't find a large chunk of the competition we have in this space that is slower and is behind on the bigger issues. I don't think they're as financially strong, I don't think they spotted the issues as quick. I do expect that this is gonna be a little messy for a couple of quarters cleaning it up, and I think it's gonna be worse for them, and it's gonna take them longer. I think ultimately that will present an opportunity. Great. Thank you. I will enjoy that opportunity a lot more than we're enjoying right now. I bet. Thank you, Mr. Meredith. Again, to ask a question, press star one. If there are no additional questions. Excuse me. The next question is from Gregory Peters with Raymond James. Your line is open. Thanks for allowing me to ask a follow-up. You know, with the focus for most of the presentation on the non-life business, I think it's probably appropriate to spend a minute and talk about the Life business, too, because that really has been, you know, a headwind because of COVID-related issues. How are you thinking about that business for this year, for fiscal year 2022 and for fiscal year 2023? Yeah, no, great question. I think it's a great business, you know, first overall. To really get a full, you know, view of the economics, I think it's important to actually take a look through statutory returns, which again, will have some of the additional return elements or investment elements in terms of hedging. You know, you'll see it made roughly, you know, $40 million if you're tracking through the year when you put this in. Not great, not bad, but about a 10% return right on the surplus that's inside that. Again, down from historical target. I highlight that because I still think you're gonna see much more of a return to kind of pre-pandemic. That's what all of our models, things of that nature would indicate. I would tell you that the pandemic continues to take turns that are unanticipated at certain points or maybe anticipated. You know, it's lasted a lot longer. Originally, you know, you thought that vaccines, and they are having a market impact. If you even look at now, while you have a, you know, an Omicron component of this, and you look at, and you sit here and say, "Well, yeah, it might be less of a severity impact in certain components just because of the speed with which it has spread," you're now actually seeing mortality rates, right, that are in excess of what they were during the second peak, associated. Hopefully, we'll get through this period, both as a country, and more broadly speaking, and things will return to, you know, more of those pre-pandemic norms. When I say short term, I think within the next year to two years, you know, each stage, I think we've gotten better at responding. When I say we, I mean the country, medicine, many things have gotten better on that front. At that same point in time, you know, there could be, you know, continued volatility from expectations or those base case expectations. Hopefully, once we're through there, what you'll see is more of a return to that, you know, long-term earnings pattern that we've had there. I can tell you from an underlying persistency in some of the economic elements underneath that if I were to think about it from a value investor or other perspective, it's increasing in value in terms of where we're going, which suggests those trends. It also is saying, "Hey, the pandemic's not gonna continue to go on for forever." When I think about a business that involves 30+ kind of year cash flow decisions that you're making. Okay, we got a year or two years again, still being, but not what we've historically had. Hopefully, that's just a minor blip in terms of what ends up being a very strong you know over period. As again, things kind of hopefully revert back to more normal and we work our way through this. Got it. Just I can't help myself. On slide nine of your presentation, you provide us the detail around your reinsurance program. For the 2021 program year for the cat aggregate program, did you use all of your $50 million in excess of $60 million, or- No, we didn't. For 2021, like, I think you're asking specifically, did we have enough cat events, you know, above the $500,000 from inside the property business to hit our retention level? Right. retention level in 2021. You did not exceed that. We didn't. You did not exceed that $50 million. We didn't get any recovery. Right. We'd not only have not used the $50 million, we didn't start using the $50 million. Interesting. All right, great. Thanks for the answers. Thank you, Mr. Peters. I will now turn the conference over to the presenters for any closing remarks. Well, thank you everybody for joining the call. We appreciate your a lot of work cut out for us here, which I think we've described. Excited to get after it, and for Brian, where you suggested we'll be hopefully a few quarters out. Thanks everybody. That concludes the Kemper fourth quarter 2021 earnings conference call. Thank you for your participation. You may now disconnect your lines.